Aeon Biopharma, Inc. reports a Return on Equity (ROE) of 358.82%.

What is AEON's dividend yield?

Aeon Biopharma, Inc. offers a dividend yield of 0.00%.

What is AEON's Quality Score?

Our AI rates AEON's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy AEON?

Our AI Timing Score for AEON is 28 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does AEON belong to?

Aeon Biopharma, Inc. is classified under the Healthcare >> Biotechnology sector on the NYSE MKT exchange

Aeon Biopharma, Inc. (AEON) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-05 | FS: 2026-03-31)

AEON AI Analysis Summary

Our AI summary for AEON: Aeon Biopharma, Inc. (NYSE MKT), Healthcare >> Biotechnology sector. The stock currently trades at ROE of 358.82%, a dividend yield of 0.00%. Its financial Quality Score stands at 62/100 — mid-range fundamentals relative to the market. The AI Timing Score is 28/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

AEON

Aeon Biopharma, Inc.

US:NYSE MKT STOCK Healthcare >> Biotechnology News 89

USD 0.29

-0.01 (-2.03%) Day Change

Watchlist Portfolio Compare Chart

-0.11

D/E

358.8%

ROE

-696.5%

ROA

0.00%

Div Yield

AEON BIOPHARMA, INC.
TYPE: STOCK
MARKET: NYSE MKT

Compare Watchlist Myport

USD 0.29 Price -0.01 (-2.03%) Day Change	NEWS SCORE: 89

AEON, the overall quality is ok ( Quality = 62) and the timing to buy is ...(Sign In to See)...

Loading chart...

62 QUALITY

Signal: NEUTRAL

Signal Description: Company financial health is OK

Reason: ROA is relatively low.
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	89
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.29
PBV / Sector	-0.86 / 44,105.10
Earning Per Share	-1.21

PE / Sector	N/A / 19.37
PEG or PE/Growth / Sector	N/A / 1.06
Average 1M Daily Value	1.08 M GREAT
Average 1W Daily Value	0.51 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 97.23
NPM Average (%) / Sector	N/A / -1,697.84
NPM Change Average (%) / Sector	N/A / 5,097.59
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-696.52 / 185,260.64
ROA Average (%) / Sector	-1,234.37 / 36,684.64
ROA Change Average (%) / Sector	193.63 / 422,221.42 GREAT
ROE (%) / Sector	358.82 / 243,761.81 GREAT
ROE Average (%) / Sector	110.53 / 48,758.38 GREAT
ROE Change Average (%) / Sector	342.81 / 424,967.86 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.42

Registration Details

Analyze Date	2026-08-06 07:59:35
Symbol	AEON
Name	AEON BIOPHARMA, INC.
Sector	Healthcare >> Biotechnology
Market	NYSE MKT
Listed Shares	48.85 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	14.46 / 9,702.21

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 5 Park Plaza, Irvine, CA, United States, 92614

Phone: 949 354 6499

Website: https://www.aeonbiopharma.com

Sector: Healthcare >> Biotechnology

Description: AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine. It also develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.